Jitendrakumar D. Sodvadiya

Jitendrakumar Sodvadiya practices at Horizon Health in Paris, Illinois, part of Horizon Health.

Jitendrakumar Sodvadiya's NPI, 1194010496, was assigned on June 14, 2011. Jitendrakumar Sodvadiya holds Illinois license 036135515.

Jitendrakumar Sodvadiya's primary practice is Horizon Health, at 721 E Court Street, Paris, IL 61944 in Edgar County. The practice phone is (217) 465-4141.

Jitendrakumar Sodvadiya's primary practice is Horizon Health in Paris, Illinois, part of Horizon Health. Jitendrakumar Sodvadiya is also affiliated with Union Hospital. The medical group on file is Horizon Health. Dmand AI also links Jitendrakumar Sodvadiya to 2 more skilled nursing facilities, 1 home health agency and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jitendrakumar Sodvadiya practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Jitendrakumar Sodvadiya's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Jitendrakumar Sodvadiya's licenses on file in 2 states: Illinois and Nebraska.

CMS data shows 11 Medicare services from Jitendrakumar Sodvadiya across 1 procedure code in 2024, for 21 Medicare patients. Medicare paid $990 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Jitendrakumar Sodvadiya in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jitendrakumar Sodvadiya's median patient age at 69, with 58% women.

In 2024, Jitendrakumar Sodvadiya wrote 10,425 Medicare Part D claims for 619 patients. 85% of them were for generic drugs. CMS names the drug for 9,773 of them, across 157 drugs with 11 or more claims each, at $715,990 in total drug cost. In 2023, CMS named 6,374 claims across 110 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Jitendrakumar Sodvadiya for performance year 2024, reported through an alternative payment model (APM). Jitendrakumar Sodvadiya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 110 general payments to Jitendrakumar Sodvadiya from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $489.